Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
118.4 USD | +0.31% | -0.34% | +18.66% |
Jul. 01 | ICU Medical, Inc.(NasdaqGS:ICUI) added to Russell 2000 Defensive Index | CI |
Jul. 01 | ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Midcap Value Index | CI |
Chart calendar ICU Medical, Inc.
Upcoming events on ICU Medical, Inc.
Past events on ICU Medical, Inc.
2024-05-15 12:00 pm | Annual General Meeting |
2024-05-07 04:30 pm | Q1 2024 Earnings Call |
2024-05-07 04:00 pm | Q1 2024 Earnings Release |
2024-03-20 02:15 pm | KeyBanc Life Sciences & MedTech Forum |
2024-03-04 07:30 pm | Raymond James Institutional Investors Conference |
2024-02-27 04:30 pm | Q4 2023 Earnings Call |
2024-02-27 04:05 pm | Q4 2023 Earnings Release |
2023-11-06 04:30 pm | Q3 2023 Earnings Call |
2023-11-06 04:05 pm | Q3 2023 Earnings Release |
2023-09-12 07:30 am | Morgan Stanley Global Healthcare Conference |
2023-08-07 04:30 pm | Q2 2023 Earnings Call |
2023-08-07 04:05 pm | Q2 2023 Earnings Release |
2023-05-17 12:00 pm | Annual General Meeting |
2023-05-08 04:30 pm | Q1 2023 Earnings Call |
2023-05-08 04:05 pm | Q1 2023 Earnings Release |
2023-03-22 10:30 am | KeyBanc Life Sciences & MedTech Forum |
2023-03-06 11:00 am | Raymond James Institutional Investors Conference |
2023-02-27 04:30 pm | Q4 2022 Earnings Call |
2023-02-27 04:00 pm | Q4 2022 Earnings Release |
2023-01-11 04:30 pm | JP Morgan Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 266 1 220 3.75% | 1 271 1 219 4.26% | 1 316 1 271 3.55% | 2 280 2 256 1.08% | 2 259 2 230 1.3% | 2 269 |
EBITDA Million USD | Released Forecast Spread | 268 267 0.42% | 243 241 0.67% | 261 258 0.97% | 359 353 1.64% | 376 373 0.91% | 350 |
EBIT Million USD | Released Forecast Spread | 107 151 -28.95% | 98,2 135 -27.37% | 123 142 -12.99% | 268 265 1.27% | 286 287 -0.34% | 259 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 115 138 -17.03% | 97,5 115 -15.11% | 123 130 -5.31% | -114 23,9 -578.86% | -78,3 -47,5 -64.82% | -119 |
Net income Million USD | Released Forecast Spread | 101 119 -14.74% | 86,9 85,7 1.37% | 103 110 -5.81% | -74,3 -76,9 3.34% | -29,7 -18,8 -58.14% | -76,4 |
EPS USD | Released Forecast Spread | 4,69 5,34 -12.23% | 4,02 3,89 3.34% | 4,74 5,00 -5.15% | -3,11 -3,41 8.71% | -1,23 -1,17 -5.58% | -3,20 |
Announcement Date | 27/02/20 | 25/02/21 | 24/02/22 | 27/02/23 | 27/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 543 557 -2.55% | 561 564 -0.55% | 598 569 5.04% | 578 583 -0.84% | 569 565 0.59% | 549 563 -2.41% | 553 571 -3.06% | 588 568 3.45% | 553 554 -0.26% | 554 | 568 | 592 | 577 | 582 |
EBITDA Million USD | Released Forecast Spread | 84,9 96,1 -11.61% | 84,7 91,2 -7.05% | 92,6 88,8 4.22% | 96,4 91,4 5.51% | 102 92,1 10.77% | 98,1 97,4 0.67% | 89,8 91,3 -1.57% | 86,3 86,6 -0.35% | 78,8 75,0 5.08% | 82,0 | 92,2 | 99,2 | 92,6 | 96,7 |
EBIT Million USD | Released Forecast Spread | 63,1 64,8 -2.7% | 61,2 59,6 2.68% | 72,6 65,1 11.44% | 71,6 69,8 2.59% | 78,8 68,9 14.38% | 75,2 73,4 2.46% | 69,1 68,8 0.47% | 62,5 63,4 -1.46% | 58,8 51,3 14.53% | 57,3 | 67,9 | 75,4 | 67,2 | 72,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -54,8 36,2 -251.38% | -16,9 34,7 -148.57% | -21,3 47,2 -145.14% | -21,4 54,3 -139.5% | ||||||||||
Net income Million USD | Released Forecast Spread | -38,1 32,8 -216.06% | -7,47 18,1 -141.41% | -13,2 3,90 -438.67% | -15,5 10,9 -242.53% | -9,81 9,70 -201.15% | -9,93 9,90 -200.34% | 7,24 | -17,1 2,40 -814.46% | -39,5 -17,0 -132.39% | -11,5 | -4,34 | 0,86 | -17,6 | -12,7 |
EPS USD | Released Forecast Spread | -1,61 0,91 -276.92% | -0,31 0,75 -141.61% | -0,55 -0,91 39.23% | -0,65 -0,44 -49.43% | -0,41 -0,23 -82.22% | -0,41 -0,05 -720% | 0,30 -0,58 151.72% | -0,71 -0,29 -149.12% | -1,63 -0,70 -134.53% | -0,61 | -0,30 | -0,07 | -0,71 | -0,51 |
Announcement Date | 09/05/22 | 08/08/22 | 07/11/22 | 27/02/23 | 08/05/23 | 07/08/23 | 06/11/23 | 27/02/24 | 07/05/24 | - | - | - | - | - |
2024-07-11 01:00 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
2024-07-12 01:00 am | ARJO AB: Q2 2024 Earnings Release |
2024-07-12 01:30 am | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
2024-07-17 | MEDMIX AG: Q2 2024 Earnings Release |
2024-07-18 07:30 am | ABBOTT LABORATORIES: Q2 2024 Earnings Release |
2024-07-19 01:00 am | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
2024-07-22 | NEOGEN CORPORATION: Q4 2024 Earnings Release (Projected) |
2024-07-23 | CONMED CORPORATION: Q2 2024 Earnings Release (Projected) |
2024-07-23 | INTEGRA LIFESCIENCES HOLDINGS CORPORATION: Q2 2024 Earnings Release (Projected) |
2024-07-24 04:00 pm | ALIGN TECHNOLOGY, INC.: Q2 2024 Earnings Release |
Past sector events for ICU Medical, Inc.
2024-07-04 | MANI, INC.: Q3 2024 Earnings Release |
2024-06-27 01:00 am | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
2024-06-18 07:00 am | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release |
2024-06-07 03:14 am | TAIDOC TECHNOLOGY CORPORATION: May 2024 Sales and Revenue Release |
2024-06-05 06:00 am | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
2024-05-27 04:30 pm | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
2024-05-23 06:45 am | MEDTRONIC PLC: Q4 2024 Earnings Release |
2024-05-22 01:00 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
2024-05-17 04:19 am | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
2024-05-16 02:00 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ICUI Stock
- Calendar ICU Medical, Inc.